Skip to content
Paradigm Health logo — Clinical Research, Re-Engineered
for Impact

Paradigm Health

Clinical Research, Re-Engineered
for Impact

Founded 2021 144 employees Series A Total: $203.00M Health Care, Life Sciences

General Information

Company Name Paradigm Health
Founded Year 2021
Employees 144
Industries Health Care, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Paradigm Health. To contact Paradigm Health, visit paradigm.inc.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Paradigm Health compare?

A PDF of Paradigm Health and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Paradigm Health soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Paradigm Health

Paradigm is a health care and life sciences startup, founded in 2021 with a slogan "Clinical research, built better for all." The company is backed by prominent investors including Lux Capital, Arch Venture Partners, F-Prime Capital, GV, General Catalyst, Magnetic Ventures, BrightEdge Fund, and Mubadala Capital Ventures, and has recently received a significant $203.00M Series A investment on 25 January 2023. Paradigm's mission is to revolutionize the clinical research ecosystem by providing a platform that offers fair access to trials for all patients while enhancing trial efficiency and reducing participation barriers for healthcare providers. The startup aims to create a seamless infrastructure at healthcare provider organizations, ultimately expediting the delivery of potentially life-saving therapies to patients.

Business keywords: clinical research, clinical trials, life sciences, patient access, trial efficiency, healthcare providers, barrier reduction, therapy access, ARCH Venture Partners, equitable access, healthcare ecosystem, clinical trial infrastructure, patient-centric

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $203.00M 8
Lux Capital, Arch Venture Partners +6
25 Jan 2023

Paradigm Health Alternatives & Competitors

View All Alternatives
Paradigm Health vs
H1
H1 United States

H1 is the connecting force for global HCP, clinical, scientific and research information.

Debt Financing
439 employees
Biotechnology, Health Care
Paradigm Health vs
1nHealth
1nHealth United States

We fill clinical trials fast because we own every step of the patient enrollment funnel.

Seed
38 employees
Big Data, Health Care
Paradigm Health vs
Macro Trials
Macro Trials United States

Purpose-built for tomorrow’s clinical trial.

Seed
15 employees
Biopharma, Health Care

FAQ About Paradigm Health

Clinical Research, Re-Engineered
for Impact
Paradigm Health was founded in 2021.
Paradigm Health operates in Health Care and Life Sciences. Its work centres on clinical research, clinical trials, life sciences and patient access.
Paradigm Health has approximately 144 employees.
Paradigm Health has completed 1 funding round, raising a total of $203.00M. The latest funding stage is Series A.
Top alternatives and competitors to Paradigm Health include H1, 1nHealth, Macro Trials, Evidera, nference. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Paradigm Health and H1 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Paradigm Health, https://bouncewatch.com/company/paradigm-1, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout